OTR Acquisition Corp. (OTRA) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
1395 BRICKELL AVENUE, SUITE 800 MIAMI, FL 33131 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)Annual | Quarterly
| 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 261,696 | 450,559 | 521,481 | 686,858 | 991,720 | 25,000 | |||
| Cash and cash equivalent | 261,696 | 450,559 | 521,481 | 686,858 | 991,720 | 25,000 | |||
| Deferred costs | 183,522 | ||||||||
| Asset, held-in-trust | 127,663 | ||||||||
| Other undisclosed current assets | 76,081 | 140,891 | 225,701 | 269,807 | 205,545 | ||||
| Total current assets: | 337,777 | 591,450 | 747,182 | 956,665 | 1,324,928 | 208,522 | |||
| Noncurrent Assets | |||||||||
| Asset, held-in-trust | 107,086,513 | 107,086,751 | 107,093,122 | 107,125,526 | 107,094,493 | ||||
| Total noncurrent assets: | 107,086,513 | 107,086,751 | 107,093,122 | 107,125,526 | 107,094,493 | ||||
| TOTAL ASSETS: | 107,424,290 | 107,678,201 | 107,840,304 | 108,082,191 | 108,419,421 | 208,522 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Debt | |||||||||
| Other undisclosed current liabilities | 176,887 | 1,471 | 5,000 | 25,000 | 155,524 | ||||
| Total current liabilities: | 176,887 | 1,471 | 5,000 | 25,000 | 155,524 | ||||
| Noncurrent Liabilities | |||||||||
| Other undisclosed noncurrent liabilities | 8,916,105 | 9,284,351 | 12,670,192 | 10,165,478 | 14,619,772 | ||||
| Total noncurrent liabilities: | 8,916,105 | 9,284,351 | 12,670,192 | 10,165,478 | 14,619,772 | ||||
| Other undisclosed liabilities | 194,201 | ||||||||
| Total liabilities: | 9,092,992 | 9,285,822 | 12,675,192 | 10,190,478 | 14,775,296 | 194,201 | |||
| Temporary equity, including noncontrolling interest | 107,085,338 | 90,165,111 | 92,891,712 | 107,085,338 | |||||
| Equity | |||||||||
| Equity, attributable to parent, including: | (8,754,040) | (8,692,959) | 5,000,001 | 5,000,001 | (13,441,213) | 14,321 | |||
| Additional paid in capital | 6,759,358 | 4,032,784 | 24,712 | ||||||
| Retained earnings (accumulated deficit) | (8,754,320) | (8,693,239) | (1,759,803) | 966,798 | (13,441,493) | (10,679) | |||
| Other undisclosed equity, attributable to parent | 280 | 280 | 446 | 419 | 280 | 288 | |||
| Other undisclosed equity | 107,085,338 | ||||||||
| Total equity: | (8,754,040) | 98,392,379 | 5,000,001 | 5,000,001 | (13,441,213) | 14,321 | |||
| TOTAL LIABILITIES AND EQUITY: | 107,424,290 | 107,678,201 | 107,840,304 | 108,082,191 | 108,419,421 | 208,522 | |||
Income Statement (P&L) (USD)Annual | Quarterly
| 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Operating expenses | (431,589) | (159,952) | (224,893) | (237,739) | (10,679) | |||
| Operating loss: | (431,589) | (159,952) | (224,893) | (237,739) | (10,679) | |||
| Nonoperating income (Investment Income, Nonoperating) | 2,262 | 1,378 | 3,006 | 31,033 | ||||
| Loss from continuing operations before income taxes: | (429,327) | (158,574) | (221,887) | (206,706) | (10,679) | |||
| Other undisclosed income from continuing operations | 250,531 | |||||||
| Loss from continuing operations: | (178,796) | (158,574) | (221,887) | (206,706) | (10,679) | |||
| Loss before gain (loss) on sale of properties: | (178,796) | (158,574) | (221,887) | (206,706) | ✕ | (10,679) | ||
| Other undisclosed net income | 117,715 | 4,454,294 | ||||||
| Net income (loss): | (61,081) | (158,574) | (221,887) | 4,247,588 | (10,679) | |||
| Other undisclosed net income (loss) attributable to parent | 3,385,841 | (2,504,714) | ||||||
| Net income (loss) attributable to parent: | (61,081) | 3,227,267 | (2,726,601) | 4,247,588 | (10,679) | |||
| Other undisclosed net income available to common stockholders, basic | 32,404 | |||||||
| Net income (loss) available to common stockholders, diluted: | (61,081) | 3,227,267 | (2,694,197) | 4,247,588 | (10,679) | |||
Comprehensive Income (USD)Annual | Quarterly
| 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (61,081) | (158,574) | (221,887) | 4,247,588 | (10,679) | |||
| Comprehensive income (loss), net of tax, attributable to parent: | (61,081) | (158,574) | (221,887) | 4,247,588 | (10,679) | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.